By Christy Santhosh (Reuters) -Dexcom forecast total annual revenue largely in line with Wall Street expectations on Monday, on bets there will be strong demand for its continuous glucose monitors for ...
Dexcom forecast total annual revenue in line with Wall Street expectations on Monday, on bets of strong demand for its continuous glucose monitors for diabetes patients, sending the medical device ...
GERMANTOWN, Md., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable ...
North Chicago-based Abbott announced last month it reached a settlement agreement with Dexcom over all outstanding patent disputes relating to their glucose monitoring products, which estimate blood ...
Type 1, which usually starts in childhood, and Type 2, which is more common in adults and linked to obesity. But researchers now know that not all Type 2 diabetes cases are the same. People with Type ...